Web Results

www.pr.com/company-profile/overview/3917

Cornerstone BioPharma, Inc., located next to North Carolina's Research Triangle Park, is an emerging specialty pharmaceutical company that is currently focused on the development and commercialization of niche prescription medications in the CNS, anti-infective, and respiratory markets. The privately held company ...

www.marketwired.com/press-release/cornerstone-therapeutics-inc-announces-name-change-to-chiesi-usa-inc-1903639.htm

Apr 28, 2014 ... CARY, NC--(Marketwired - Apr 28, 2014) - Cornerstone Therapeutics Inc., a specialty pharmaceutical company focused on commercializing products for the U.S. hospital and adjacent specialty markets, today announced an official name change to Chiesi USA, Inc. following the completion of its acquisition ...

www.linkedin.com/company/cornerstone-biopharma

Learn about working at Cornerstone Biopharma. Join LinkedIn today for free. See who you know at Cornerstone Biopharma, leverage your professional network, and get hired.

bciq.biocentury.com/companies/cornerstone_therapeutics_inc

Cornerstone Therapeutics' detailed financings; Comprehensive pipeline breakdown, including molecular targets & partnerships. 17 years of in-depth BioPharma industry analysis.

www.nasdaq.com/markets/ipos/company/cornerstone-therapeutics-inc-155524-38406

Company Name, CORNERSTONE THERAPEUTICS INC. Company Address, 1255 CRESCENT GREEN DRIVE SUITE 250. CARY, NC 27518. Company Phone, 919-678-6611. Company Website, www.criticaltherapeutics.com. CEO, Paul Rubin, M.D.. Employees (as of 4/15/2004), 32. State of Inc, DE. Fiscal Year End, 12/ ...

rafaelpharma.com

At Rafael Pharmaceuticals, Inc. we are a pioneering, clinical-stage, metabolic oncology therapeutics company, focused on transforming the lives of patients with hard to treat cancers.

www.chiesiusa.com

Home About us History Mission & values Our management Compliance Products Research & development Clinical transparency News Social responsibility Expanded access programs Join our team Our culture Our workplace Our people Our pay and benefits Current openings Contact us Patient support Business ...

www.bloomberg.com/research/stocks/private/snapshot.asp?privcapId=991815

As of October 31, 2008, Critical Therapeutics Inc. was acquired by Cornerstone BioPharma Holdings, Inc., in a reverse merger transaction. Critical Therapeutics, Inc., a biopharmaceutical company, engages in developing and commercializing products to treat respiratory, inflammatory, and critical care diseases linked to ...

www.prnewswire.com/news-releases/chiesi-farmaceutici-completes-acquisition-of-cornerstone-therapeutics-243471541.html

Feb 4, 2014 ... PARMA, Italy and CARY, N.C., Feb. 4, 2014 /PRNewswire/ -- Chiesi Farmaceutici S.p.A. ("Chiesi"), a leading European pharmaceutical company, and Cornerstone Therapeutics Inc. (NASDAQ: CRTX) ("Cornerstone"), a specialty pharmaceutical company focused on commercializing products for the U.S. ...